Pharmaceutical composition using aliskiren and avosentan

Details for Australian Patent Application No. 2007338040 (hide)

Owner Novartis AG

Inventors Baltatu, Ovidiu; Schumacher, Christoph; Zaugg, Christian; Huxley, Alice

Agent Spruson & Ferguson

Pub. Number AU-A-2007338040

PCT Pub. Number WO2008/077916

Priority 06127175.5 22.12.06 EP

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/077916 Priority application(s): WO2008/077916

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338045-Phytosanitary formulation generating nanoparticles, method for preparing nanoparticles and use thereof

2007338031-Process for preparing fluoromethyl-substituted heterocyclic compounds